𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Multivariate Analysis of HIV-1 Protease Inhibitors and Resistance Induced by Mutation.

✍ Scribed by Anna Maria Almerico; Marco Tutone; Antonino Lauria; Patrizia Diana; Paola Barraja; Alessandra Montalbano; Girolamo Cirrincione; Gaetano Dattolo

Publisher
John Wiley and Sons
Year
2006
Weight
8 KB
Volume
37
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Diverse pattern of protease inhibitor re
Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir
✍ Veronica Svedhem; A. Lindkvist; T. Bergroth; Lidman Knut; A. SΓΆnnerborg πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 70 KB

## Abstract The aim of the study was to describe the pattern of resistance mutations in human immunodeficiency virus type 1 (HIV‐1) infected patients experiencing their first protease inhibitor (PI) failure on nelfinavir (NFV)‐containing therapy. Earlier PI‐naΓ―ve patients (n = 172) with NFV‐contain

Chemometric classification of HIV-1 prot
Chemometric classification of HIV-1 protease inhibitors
✍ Luciana J. O. Figueiredo; O. A. C. Antunes πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

This work presents a chemometric classification for a set of 24 known HIV-1 protease inhibitors, based on two pattern recognition methods widely used in quantitative structure-activity (QSAR) studies: soft independent modeling of class analogy (SIMCA) and Kth nearest neighbors (KNN) with the aim of

Emergence and genetic evolution of HIV-1
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors
✍ Cabana, Marta; Clotet, Bonaventura; MartοΏ½nez, Miguel-Angel πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 302 KB

The emergence of genotypic resistance in protease and reverse transcriptase (RT) gene regions was longitudinally evaluated in plasma samples from a group of 12 HIV-1-infected patients treated with different combination of antiretroviral therapies and selected on the basis of their clinical failure.